Maternal and fetal outcomes in placenta accreta after institution of team-managed care

Reproductive Sciences

Volumn 21, Issue 6, 2014, Pages 761-771

  Al Khan, Abdulla ^a,b   Gupta, Vivek ^a,b   Illsley, Nicholas P ^a,b   Mannion, Ciaran ^b   Koenig, Christopher ^b   Bogomol, Adam ^b   Alvarez, Manuel ^a,b   Zamudio, Stacy ^a,b  

^a Department of Obstetrics and Gynecology Division of Maternal Fetal Medicine and Surgery Center for Abnormal Placentation   (United States)

^b HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

increta; percreta; peripartum hemorrhage; surgical management; transfusion

Indexed keywords

ADULT; ARTICLE; BLEEDING; CESAREAN SECTION; DISEASE SEVERITY; ERYTHROCYTE CONCENTRATE; FEMALE; FETUS OUTCOME; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PLACENTA ACCRETA; PLACENTA PREVIA; PRIORITY JOURNAL; RISK FACTOR; SURGICAL TECHNIQUE; TREATMENT OUTCOME; COHORT ANALYSIS; DISEASE MANAGEMENT; MIDDLE AGED; NEWBORN; PATIENT CARE; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDY; TRENDS; YOUNG ADULT;

ADULT; COHORT STUDIES; DISEASE MANAGEMENT; FEMALE; HUMANS; INFANT, NEWBORN; MIDDLE AGED; PATIENT CARE TEAM; PLACENTA ACCRETA; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84900433010     PISSN: 19337191     EISSN: 19337205     Source Type: Journal    
DOI: 10.1177/1933719113512528     Document Type: Article

References (41)

1. Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth. 2009 ; 9: 55
2. Knight M. Peripartum hysterectomy in the UK: management and outcomes of the associated haemorrhage. BJOG. 2007 ; 114 (11). 1380-1387
3. Kastner ES, Figueroa R, Garry D, Maulik D. Emergency peripartum hysterectomy: experience at a community teaching hospital. Obstet Gynecol. 2002 ; 99 (6). 971-975
4. Muench MV, Baschat AA, Oyelese Y, Kush ML, Mighty HE, Malinow AM. Gravid hysterectomy: a decade of experience at an academic referral center. J Reprod Med. 2008 ; 53 (4). 271-278
5. Oyelese Y, Smulian JC. Placenta previa, placenta accreta, and vasa previa. Obstet Gynecol. 2006 ; 107 (4). 927-941
6. Khong TY. The pathology of placenta accreta, a worldwide epidemic. J Clin Pathol. 2008 ; 61 (12). 1243-1246
7. Mazouni C, Gorincour G, Juhan V, Bretelle F. Placenta accreta: a review of current advances in prenatal diagnosis. Placenta. 2007 ; 28 (7). 599-603
8. Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008 ; 29 (7). 639-645
9. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005 ; 192 (5). 1458-1461
10. Number 266, January 2002: placenta accreta. Obstet Gynecol. 2002 ; 99 (1). 169-170
11. Miller DA, Chollet JA, Goodwin TM. Clinical risk factors for placenta previa-placenta accreta. Am J Obstet Gynecol. 1997 ; 177 (1). 210-214
12. Belfort MA. Placenta accreta. Am J Obstet Gynecol. 2010 ; 203 (5). 430-439
13. Esh-Broder E, Ariel I, Abas-Bashir N, Bdolah Y, Celnikier DH. Placenta accreta is associated with IVF pregnancies: a retrospective chart review. BJOG. 2011 ; 118 (9). 1084-1089
14. Mazouni C, Palacios-Jaraquemada JM, Deter R, Juhan V, Gamerre M, Bretelle F. Differences in the management of suspected cases of placenta accreta in France and Argentina. Int J Gynaecol Obstet. 2009 ; 107 (1). 1-3
15. Warshak CR, Ramos GA, Eskander R, et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol. 2010 ; 115 (1). 65-69
16. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG. 2009 ; 116 (5). 648-654
17. Olsen IE, Groveman SA, Lawson ML, Clark RH, Zemel BS. New intrauterine growth curves based on United States data. Pediatrics. 2010 ; 125 (2). e214 - e224
18. Palacios Jaraquemada JM, Bruno CH. Magnetic resonance imaging in 300 cases of placenta accreta: surgical correlation of new findings. Acta Obstet Gynecol Scand. 2005 ; 84 (8). 716-724
19. JainNJDenkCEValenteSSchollT. 2007Pregnancy Risk Assessment Monitoring System (NJ-PRAMS): A survey for healthier babies in New Jersey. Pre-pregnancy weight status and pregnancy weight gain. http://www.nj.gov/health/fhs/ professional/prams.shtmlAccessed November 12, 2013.
20. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004 ; 103 (2). 219-224
21. Stotler B, Padmanabhan A, Devine P, Wright J, Spitalnik SL, Schwartz J. Transfusion requirements in obstetric patients with placenta accreta. Transfusion. 2011 ; 51 (12). 2627-2633
22. O'Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol. 1996 ; 175 (6). 1632-1638
23. Amsalem H, Kingdom JC, Farine D, et al. Planned caesarean hysterectomy versus "conserving" caesarean section in patients with placenta accreta. J Obstet Gynaecol Can. 2011 ; 33 (10). 1005-1010
24. Sentilhes L, Ambroselli C, Kayem G, et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol. 2010 ; 115 (3). 526-534
25. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv. 2007 ; 62 (8). 529-539
26. Jauniaux E, Jurkovic D. Placenta accreta: pathogenesis of a 20th century iatrogenic uterine disease. Placenta. 2012 ; 33 (4). 244-251
27. Hung TH, Shau WY, Hsieh CC, Chiu TH, Hsu JJ, Hsieh TT. Risk factors for placenta accreta. Obstet Gynecol. 1999 ; 93 (4). 545-550
28. Reed CB. Adherent placenta. JAMA. 1899 ; 32 (18). 971-975
29. Ananth CV, Smulian JC, Vintzileos AM. The association of placenta previa with history of cesarean delivery and abortion: a metaanalysis. Am J Obstet Gynecol. 1997 ; 177 (5). 1071-1078
30. Onwere C, Gurol-Urganci I, Cromwell DA, Mahmood TA, Templeton A, van der Meulen JH. Maternal morbidity associated with placenta praevia among women who had elective caesarean section. Eur J Obstet Gynecol Reprod Biol. 2011 ; 159 (1). 62-66
31. Betran AP, Merialdi M, Lauer JA, et al. Rates of caesarean section: analysis of global, regional and national estimates. Paediatr Perinatal Epidemiol. 2007 ; 21 (2). 98-113
32. Earl U, Bulmer JN, Briones A. Placenta accreta: an immunohistological study of trophoblast populations. Placenta. 1987 ; 8 (3). 273-282
33. Wells M, Bulmer JN. The human placental bed: histology, immunohistochemistry and pathology. Histopathology. 1988 ; 13 (5). 483-498
34. Khong TY, Robertson WB. Placenta creta and placenta praevia creta. Placenta. 1987 ; 8 (4). 399-409
35. Wehrum MJ, Buhimschi IA, Salafia C, et al. Accreta complicating complete placenta previa is characterized by reduced systemic levels of vascular endothelial growth factor and by epithelial-to-mesenchymal transition of the invasive trophoblast. Am J Obstet Gynecol. 2011 ; 204 (5). e411-411
36. Hannon T, Innes BA, Lash GE, Bulmer JN, Robson SC. Effects of local decidua on trophoblast invasion and spiral artery remodeling in focal placenta creta - an immunohistochemical study. Placenta. 2012 ; 33 (12). 998-1004
37. Clifton VL. Review: sex and the human placenta: mediating differential strategies of fetal growth and survival. Placenta. 2010 ; 31 suppl: S33 - S39
38. Khong TY, Staples A, Chan AS, Keane RJ, Wilkinson CS. Pregnancies complicated by retained placenta: sex ratio and relation to pre-eclampsia. Placenta. 1998 ; 19 (8). 577-580
39. Wong HS, Zuccollo J, Tait J, Pringle KC. Placenta accreta in the first trimester of pregnancy: sonographic findings. J Clin Ultrasound. 2009 ; 37 (2). 100-103
40. Comstock CH, Lee W, Vettraino IM, Bronsteen RA. The early sonographic appearance of placenta accreta. J Ultrasound Med. 2003 ; 22 (1). 19-23
41. Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet Gynecol. 2010 ; 116 (4). 835-842